Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection

PLoS Pathogens

Volumn 12, Issue 7, 2016, Pages

  Muir, Roshell ^a   Metcalf, Talibah ^a   Tardif, Virginie ^a   Takata, Hiroshi ^b,c   Phanuphak, Nittaya ^d   Kroon, Eugene ^d   Colby, Donn J ^d   Trichavaroj, Rapee ^e   Valcour, Victor ^f   Robb, Merlin L ^b,c   Michael, Nelson L ^c   Ananworanich, Jintanat ^b,c,d   Trautmann, Lydie ^b,c   Haddad, Elias K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c US Military HIV Research Program   (United States)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RANTES; TUMOR NECROSIS FACTOR ALPHA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL SURVIVAL; COCULTURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; PHENOTYPIC VARIATION; VIREMIA; VIRUS LOAD; WESTERN BLOTTING; ADULT; COHORT ANALYSIS; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE;

ADULT; ANTI-HIV AGENTS; B-LYMPHOCYTES; COCULTURE TECHNIQUES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL LOAD;

EID: 84982994525     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005777     Document Type: Article

References (49)

1. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001;193(2):169–80. 11148221; PubMed Central PMCID: PMCPMC2193337.
2. Cellerai C, Harari A, Stauss H, Yerly S, Geretti AM, Carroll A, et al. Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors. PLoS One. 2011;6(4):e18164. doi: 10.1371/journal.pone.001816421483676; PubMed Central PMCID: PMCPMC3071718.
3. Ananworanich J, Dube K, Chomont N, How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?Curr Opin HIV AIDS. 2015;10(1):18–28. doi: 10.1097/COH.000000000000012225415421; PubMed Central PMCID: PMCPMC4271317.
4. Altfeld M, Walker BD, Less is more? STI in acute and chronic HIV-1 infection. Nat Med. 2001;7(8):881–4. doi: 10.1038/9090111479610.
5. Daucher M, Price DA, Brenchley JM, Lamoreaux L, Metcalf JA, Rehm C, et al. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. J Virol. 2008;82(8):4102–14. doi: 10.1128/JVI.02212-0718234797; PubMed Central PMCID: PMCPMC2292997.
6. Cubas R, van Grevenynghe J, Wills S, Kardava L, Santich BH, Buckner CM, et al. Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection. J Immunol. 2015. doi: 10.4049/jimmunol.150152426546609.
7. van Grevenynghe J, Procopio FA, He Z, Chomont N, Riou C, Zhang Y, et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med. 2008;14(3):266–74. doi: 10.1038/nm172818311149.
8. Fletcher CV, Staskus K, Wietgrefe SW, Rothenberger M, Reilly C, Chipman JG, et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A. 2014;111(6):2307–12. doi: 10.1073/pnas.131824911124469825; PubMed Central PMCID: PMCPMC3926074.
9. Moir S, Fauci AS, B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235–45. doi: 10.1038/nri252419319142; PubMed Central PMCID: PMCPMC2779527.
10. Cagigi A, Nilsson A, De Milito A, Chiodi F, B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design. Vaccine. 2008;26(24):3016–25. doi: 10.1016/j.vaccine.2007.11.06318164520.
11. van Grevenynghe J, Cubas RA, Noto A, DaFonseca S, He Z, Peretz Y, et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. J Clin Invest. 2011;121(10):3877–88. doi: 10.1172/JCI5921121926463; PubMed Central PMCID: PMCPMC3195482.
12. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM, Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992;89(2):561–6. doi: 10.1172/JCI1156211737846; PubMed Central PMCID: PMCPMC442888.
13. Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, Ehler LA, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A. 2001;98(18):10362–7. doi: 10.1073/pnas.18134789811504927; PubMed Central PMCID: PMCPMC56966.
14. Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med. 2004;200(7):587–99. 15508184.
15. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797–805. doi: 10.1084/jem.2007268318625747; PubMed Central PMCID: PMCPMC2525604.
16. Malaspina A, Moir S, Chaitt DG, Rehm CA, Kottilil S, Falloon J, et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood. 2007;109(5):2086–8. doi: 10.1182/blood-2006-06-03138517053062; PubMed Central PMCID: PMCPMC1801046.
17. Chong Y, Ikematsu H, Kikuchi K, Yamamoto M, Murata M, Nishimura M, et al. Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patients. AIDS Res Hum Retroviruses. 2004;20(2):219–26. doi: 10.1089/08892220477300494115018710.
18. De Milito A, Morch C, Sonnerborg A, Chiodi F, Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS. 2001;15(8):957–64. 11399977.
19. Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol. 2007;178(12):8212–20. 17548660.
20. Crotty S, Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621–63. doi: 10.1146/annurev-immunol-031210-10140021314428.
21. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108–21. doi: 10.1016/j.immuni.2010.12.01221215658; PubMed Central PMCID: PMCPMC3046815.
22. He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770–81. doi: 10.1016/j.immuni.2013.09.00724138884.
23. Bentebibel SE, Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med. 2013;5(176):176ra32. doi: 10.1126/scitranslmed.300519123486778; PubMed Central PMCID: PMCPMC3621097.
24. Cubas RA, Mudd JC, Savoye AL, Perreau M, van Grevenynghe J, Metcalf T, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med. 2013;19(4):494–9. doi: 10.1038/nm.310923475201; PubMed Central PMCID: PMCPMC3843317.
25. Ananworanich J, Phanuphak N, de Souza M, Paris R, Arroyo M, Trichavaroj R, et al. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr. 2008;49(2):151–5. doi: 10.1097/QAI.0b013e318183a96d18769355.
26. Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012;7(3):e33948. doi: 10.1371/journal.pone.003394822479485; PubMed Central PMCID: PMCPMC3316511.
27. Ananworanich J, Fletcher JL, Pinyakorn S, van Griensven F, Vandergeeten C, Schuetz A, et al. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology. 2013;10:56. doi: 10.1186/1742-4690-10-5623718762; PubMed Central PMCID: PMCPMC3669623.
28. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187(1):129–34. 9419219; PubMed Central PMCID: PMCPMC2199181.
29. Mannel DN, Echtenacher B, TNF in the inflammatory response. Chem Immunol. 2000;74:141–61. 10608086.
30. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG, Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71–109. doi: 10.1146/annurev-immunol-031210-10131221166540.
31. Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, Briere F, et al. Generation of memory B cells and plasma cells in vitro. Science. 1995;268(5211):720–2. 7537388.
32. Vinuesa CG, Tangye SG, Moser B, Mackay CR, Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol. 2005;5(11):853–65. doi: 10.1038/nri171416261173.
33. Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med. 2009;6(7):e1000107. doi: 10.1371/journal.pmed.100010719582166; PubMed Central PMCID: PMCPMC2702159.
34. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103(6):2180–6. doi: 10.1182/blood-2003-07-237514604962.
35. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, Tassandin C, et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS. 2005;19(17):1947–55. 16260900.
36. Schmitt N, Bentebibel SE, Ueno H, Phenotype and functions of memory Tfh cells in human blood. Trends Immunol. 2014;35(9):436–42. doi: 10.1016/j.it.2014.06.00224998903; PubMed Central PMCID: PMCPMC4152409.
37. Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL, et al. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity. 2013;39(4):758–69. doi: 10.1016/j.immuni.2013.08.03124035365; PubMed Central PMCID: PMCPMC3996844.
38. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S, et al. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog. 2014;10(1):e1003853. doi: 10.1371/journal.ppat.100385324497824; PubMed Central PMCID: PMCPMC3911819.
39. Wakkach A, Cottrez F, Groux H, Can interleukin-10 be used as a true immunoregulatory cytokine?Eur Cytokine Netw. 2000;11(2):153–60. 10903794.
40. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett. 2003;86(2):123–9. 12644313.
41. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C, Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev. 2008;223:114–31. doi: 10.1111/j.1600-065X.2008.00635.x18613832.
42. Tan J, Jin X, Zhao R, Wei X, Liu Y, Kong X, Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer. Oncol Rep. 2015;33(3):1512–8. doi: 10.3892/or.2014.368425529861.
43. Ma CS, Hare NJ, Nichols KE, Dupre L, Andolfi G, Roncarolo MG, et al. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J Clin Invest. 2005;115(4):1049–59. doi: 10.1172/JCI2313915761493; PubMed Central PMCID: PMCPMC1059448.
44. Moir S, Buckner CM, Ho J, Wang W, Chen J, Waldner AJ, et al. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood. 2010;116(25):5571–9. doi: 10.1182/blood-2010-05-28552820837780; PubMed Central PMCID: PMCPMC3031405.
45. Pensieroso S, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci U S A. 2009;106(19):7939–44. doi: 10.1073/pnas.090170210619416836; PubMed Central PMCID: PMCPMC2683072.
46. Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog. 2014;10(12):e1004543. doi: 10.1371/journal.ppat.100454325503054; PubMed Central PMCID: PMCPMC4263756.
47. Gianella S, Anderson CM, Richman DD, Smith DM, Little SJ, No evidence of posttreatment control after early initiation of antiretroviral therapy. AIDS. 2015;29(16):2093–7. doi: 10.1097/QAD.000000000000081626544575; PubMed Central PMCID: PMCPMC4638137.
48. De Souza MS, Phanuphak N, Pinyakorn S, Trichavaroj R, Pattanachaiwit S, Chomchey N, et al. Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection. AIDS. 2015;29(7):793–800. doi: 10.1097/QAD.000000000000061625985402.
49. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871–9. doi: 10.1097/01.aids.0000076308.76477.b812960819.